Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Return on Equity (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Return on Equity for 5 consecutive years, with 3.16% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 85.0% year-over-year to 3.16%, compared with a TTM value of 3.16% through Sep 2025, up 85.0%, and an annual FY2024 reading of 29.56%, down 2448.0% over the prior year.
  • Return on Equity was 3.16% for Q3 2025 at Lucid Diagnostics, up from 44.47% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.72% in Q1 2022 and bottomed at 8832.14% in Q1 2025.
  • Average Return on Equity over 5 years is 584.62%, with a median of 3.26% recorded in 2024.
  • The sharpest move saw Return on Equity surged 42216bps in 2024, then crashed -882233bps in 2025.
  • Year by year, Return on Equity stood at 1.83% in 2021, then fell by -21bps to 2.22% in 2022, then tumbled by -19257bps to 429.93% in 2023, then skyrocketed by 98bps to 7.76% in 2024, then soared by 59bps to 3.16% in 2025.
  • Business Quant data shows Return on Equity for LUCD at 3.16% in Q3 2025, 44.47% in Q2 2025, and 8832.14% in Q1 2025.